Crossmark

Screening of AS101 analog, organotellurolate (IV) compound 2 for its in vitro biocompatibility, anticancer, and antibacterial activities

Published Online: 2023-05-25

Published Print: 2023-07

Authors

Tripathi, Abhishek

Khan, Amreen

Kiran, Pallavi

Shetty, Harsha

Srivastava, Rohit
License Information

Text and Data Mining valid from 2023-05-25

Version of Record valid from 2023-05-25
More Information

Article History

Received: 4 January 2023

Accepted: 10 May 2023

First Online: 25 May 2023

Declarations

:

: The authors declare no conflict of interest.

Document is current